Literature DB >> 4834891

Lung tissue elastin composition in newborn infants with the respiratory distress syndrome and other diseases.

H E Evans, S Keller, I Mandl.   

Abstract

Amino acid analysis of human fetal lung elastin was undertaken in 49 instances of live-born neonates, ranging from 380 g to full term, and in 3 abortuses of 12-14 wk gestation. The data suggest that formation of the cross-linking agents, desmosine and isodesmosine, occurs early, between 14 and 22 wk. The ratio of neutral to charged amino acids remains low until the 36th wk when it attains adult levels. The composition of elastin was independent of sex and duration of survival. In three neonatal pulmonary diseases (respiratory distress syndrome, atelectasis, and hemorrhage) ratios were significantly lower than those found in nondiseased lungs. This may be a reflection of immaturity or may be a predisposing factor in neonatal lung disease. The latter hypothesis is attractive and receives indirect support from the association of a more polar elastin with other diseases, including adult emphysema and atheromatous aortic change.Our finding of relatively high polarity in elastin from human fetal lung is consistent with previous observations in a variety of fetal organs of other species.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4834891      PMCID: PMC301543          DOI: 10.1172/JCI107746

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  11 in total

1.  The structure and chemical characterization of elastic fibers as revealed by elastase and by electron microscopy.

Authors:  A I LANSING; T B ROSENTHAL; M ALEX; E W DEMPSEY
Journal:  Anat Rec       Date:  1952-12

2.  The relationship between elastin and an acidic protein in mammalian uterus.

Authors:  J W Downie; F S LaBella; S Whitaker
Journal:  Connect Tissue Res       Date:  1973       Impact factor: 3.417

3.  Studies of human pulmonary connective tissue. II. Amino acid composition of residues following collagenase digestion of lung connective tissues.

Authors:  M Fitzpatrick; V D Hospelhorn
Journal:  Am Rev Respir Dis       Date:  1965-11

4.  Studies on the nature of the "microfibrillar" component of elastic fibers.

Authors:  B Robert; M Szigeti; J C Derouette; L Robert
Journal:  Eur J Biochem       Date:  1971-08-25

5.  Amino acid composition of elastin in the developing human aorta.

Authors:  F S Labella; S Vivian
Journal:  Biochim Biophys Acta       Date:  1967-02-21

6.  Chemical compositions of elastins isolated from aortas and pulmonary tissues of humans of different ages.

Authors:  R John; J Thomas
Journal:  Biochem J       Date:  1972-03       Impact factor: 3.857

7.  Developing elastic tissue. An electron microscopic study.

Authors:  E N Albert
Journal:  Am J Pathol       Date:  1972-10       Impact factor: 4.307

8.  The protein and lipid composition of arterial elastin and its relationship to lipid accumulation in the atherosclerotic plaque.

Authors:  D M Kramsch; C Franzblau; W Hollander
Journal:  J Clin Invest       Date:  1971-08       Impact factor: 14.808

9.  Biochemical development of surface activity in mammalian lung. IV. Pulmonary lecithin synthesis in the human fetus and newborn and etiology of the respiratory distress syndrome.

Authors:  L Gluck; M V Kulovich; A I Eidelman; L Cordero; A F Khazin
Journal:  Pediatr Res       Date:  1972-02       Impact factor: 3.756

10.  The elastic fiber. I. The separation and partial characterization of its macromolecular components.

Authors:  R Ross; P Bornstein
Journal:  J Cell Biol       Date:  1969-02       Impact factor: 10.539

View more
  2 in total

1.  A compilation of amino acid analyses of proteins. XVIII. Residues per thousand residues--5.

Authors:  D M Kirschenbaum
Journal:  Appl Biochem Biotechnol       Date:  1983-08       Impact factor: 2.926

Review 2.  Elastin metabolism and chemistry: potential roles in lung development and structure.

Authors:  R B Rucker; M A Dubick
Journal:  Environ Health Perspect       Date:  1984-04       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.